Search Results
390 items found for "Danhua Ma"
- Glyco-sulfo hotspots in the chemokine receptor system
CCR5 O-glycosylation, which is under investigation in this study, also plays a major role in promoting GalNAc-Ts, GalNAc-T1 was shown to be the most likely candidate for directly glycosylating CCR5 although T11 may although direct effects of O-glycosylation removal are ruled out it is possible that indirect effects may also contribute to the observed phenotype since many glycosyltransferases and the two TPSTs also carry understanding on the dynamics and biological relevance of these PTMs in the chemokine receptor system which may
- 📰 GPCR Weekly News, February 6 to 12, 2023
Deadline extended to March 31st, 2023. (February 20 - March 3, 2023). (March 2, 2023) GEM2023. (March 14-17, 2023). SLAS 2023 B Building Biology in 3D Symposium. (May 22 - 26, 2023) 2nd LEAPS Meets Life Sciences Conference. (May 14 - 19, 2023) 8th and final ERNEST Meeting in Crete. (May 3 - 7, 2023).
- New role of β-arrestins in MOR signaling
the response to nociception, i.e. the response of the nervous system to painful stimuli; the 1970s marked The opioid system is composed of a set of major endogenous opioid peptides (EOPs): β-endorphin, enkephalins Opioid receptors belong to class A of G protein-coupled receptors or GPCRs and signaled mainly through Faouzi A, Varga BR, Majumdar S. Biased Opioid Ligands. Manhapra A. Complex Persistent Opioid Dependence-an Opioid-induced Chronic Pain Syndrome.
- 📰 GPCR Weekly News, January 30 to February 5, 2023
GPCRs in Cardiology, Endocrinology, and Taste Receptor autoantibodies: Associations with cardiac markers (February 20 - March 3, 2023). (March 2, 2023) GEM2023. (March 14-17, 2023). SLAS 2023 B uilding Biology in 3D Symposium. (May 22 - 26, 2023) 2nd LEAPS Meets Life Sciences Conference. (May 14 - 19, 2023) 8th and final ERNEST Meeting in Crete. (May 3 - 7, 2023).
- 📰 GPCR Weekly News, January 23 to 29, 2023
Reviews, GPCRs, and more Pharmacological Profiling of a Brugia malayi Muscarinic Acetylcholine Receptor SLAS2023 International Conference and Exhibition (February 25 - March 1, 2023). 2nd ERNEST Training School (February 20 - March 3, 2023). GEM2023. (March 14-17, 2023). (May 22 - 26, 2023) 2nd LEAPS Meets Life Sciences Conference. (May 14 - 19, 2023) 8th and final ERNEST Meeting in Crete. (May 3 - 7, 2023).
- Unlocking the Therapeutic Potential of Previously Undruggable GPCRs
GPCRs are an important class of drug targets that represent approximately 30% of global drug market sales However, the receptors that these medicines target have been described as the ‘low-hanging’ fruit, and many While these small protein GPCRs are valuable drug targets linked to serious diseases, many remain undrugged remaining non-sensory receptors, with functions more readily linked to pathology, are currently the main This characteristic provides a major advantage in drug discovery: massive parallel library-based screening
- 📰 GPCR Weekly News, January 16 to 22, 2023
Methods & Updates in GPCR Research Mapping of structural arrangement of cells and collective calcium SLAS2023 International Conference and Exhibition (February 25 - March 1, 2023). 2nd ERNEST Training School (February 20 - March 3, 2023). GEM2023. (March 14-17, 2023). (May 22 - 26, 2023) 2nd LEAPS Meets Life Sciences Conference. (May 14 - 19, 2023) 8th and final ERNEST Meeting in Crete. (May 3 - 7, 2023).
- 📰 GPCR Weekly News - January 9 to 15, 2023
Mandibulofacial dysostosis with alopecia results from gain-of-ETAR function via allosteric effects on The molecular associations in clathrin-coated pit regulate β-arrestin-mediated MAPK signaling downstream SLAS2023 International Conference and Exhibition (February 25 - March 1). (May 22 - 26, 2023) 2nd ERNEST Training School. (February 20 - March 3, 2023). GEM2023. (March 14-17, 2023). 8th and final ERNEST Meeting in Crete. (May 3-7, 2023).
- Odorant receptors – a bit of smell for drug discovery
Odorant receptors (ORs) belong to the G protein-coupled receptor (GPCR) family and are the largest known mammalian variable from more than 60 ORs in the testis and only a few ORs in the liver (Flegel C. et al. 2013; Maßberg expressed ORs, although there are highly increased in prostate tissue, especially in prostate cancer (Maßberg In the cardiovascular system, ORs have the potential to operate as the main carriers of endogenously In the gastrointestinal system, ORs may significantly contribute to abnormal bowel functions.
- 📰 GPCR Weekly News - January 2 to 8, 2023
Pharmacological Profiling of a Brugia malayi Muscarinic Acetylcholine Receptor as a Putative Antiparasitic Industry News Arcoscreen selected by START Lausanne to pitch at the START Global summit on the 23-24th March GPCR-Targeted Drug Discovery Summit | February 21-23, Boston. 2nd ERNEST Training School – February 20th to March GEM2023 (14-17 March 2023). 8th and final ERNEST Meeting May 3-7, 2023 in Crete. GPCR Jobs Biotechnology and Biological Sciences Doctoral Training Programme Senior QM Manager Director
- 📰 GPCR Weekly News
Oncology and Immunology Clinical, pathophysiologic, genetic and therapeutic progress in Primary Bilateral Macronodular Deletion of macrophage Gpr101 disrupts their phenotype and function dysregulating host immune responses Transcriptome profiling of male and female Ascaris lumbricoides reproductive tissues. Middle-Down Mass Spectrometry Reveals Activity-Modifying Phosphorylation Barcode in a Class C G Protein-Coupled GEM2023 (14-17 March 2023). 8th and final ERNEST Meeting May 3-7, 2023 in Crete.
- 📰 GPCR Weekly News
GPCRs in Neuroscience Photopharmacological manipulation of amygdala metabotropic glutamate receptor mGlu4 Methods & Updates in GPCR Research 3,4-Bis(hydroxymethyl)hexane-1,6-diol-based Maltosides (HDMs) for GPCR-Targeted Drug Discovery Summit | February 21-23, Boston. 2nd ERNEST Training School – February 20th to March GEM2023 (14-17 March 2023). 8th and final ERNEST Meeting May 3-7, 2023 in Crete.
- 📰 GPCR Weekly News
patient-derived xenografts of colorectal carcinoma in mice Methods & Updates in GPCR Research Middle-Down Mass GPCR early career investigator (ECI) Zoominar Survey 2nd ERNEST Training School – February 20th to March GEM2023 (14-17 March 2023). 8th and final ERNEST Meeting May 3-7, 2023 in Crete.
- 📰 GPCR Weekly News
control of GPCR signaling by bistable animal opsins MosOpn3 and LamPP in a molecular property-dependent manner GPCR-Targeted Drug Discovery Summit | February 21-23, Boston. 2nd ERNEST Training School – February 20th to March GEM2023 (14-17 March 2023). 8th and final ERNEST Meeting May 3-7, 2023 in Crete.
- Transmembrane domains of GPCR dimers – a novel hot spot for drug discovery
M. et al. 2018; Manglik, A. et al. 2012). the dimerization interface is affected by the activation state of the receptors, with the interface mainly located at TM4 and TM5 when mGluR2 dimers are inactive, switching to an interface mainly at TM6 when Mantas et al. 2022).
- Therapeutic validation of an orphan G protein‐coupled receptor
, such as sensory perception, reproduction, development, growth, metabolism, and are also linked to major Therefore, matching a ligand to an orphan GPCRs, the process of de-orphanizing, is of great importance & Ma'ayan, 2020). , 2020) and efforts have been made to discover GPR84 antagonists. In this study Marsango et al. address two key questions in GPR84 biology and pharmacology: 1. how GPR84
- TM5-TM6: structural switches that modulate the coupling of serotonin receptors to Gs or Gi
These differences are mainly attributed to the characteristic Ras domain distance between Gs and Gi. Therefore the authors propose that the relative lengths of TM5 and TM6 in serotonin receptors function as a macro-switch was 5.6 ± 1.5 residues longer while TM6 was 2.6 ± 1.6 residues shorter, concluding that the TM5-TM6 macro-switch
- Ode to GPCRs
Moreover, the G protein-independent pathway is mainly regulated by arrestin, which recognizes and binds The 1994 Nobel Prize in Physiology or Medicine was awarded to Alfred Goodman Gilman and Martin Rodbell Mayo Clinic proceedings. Mayo Clinic 68, 262 (1993). https://doi.org/10.1016/S0025-6196(12)60046-9/. 19. Sir James Whyte Black OM. 14 June 192422 March 2010.
- Location bias contributes to functionally selective responses of biased CXCR3 agonists
Although GPCRs are primarily found at the plasma membrane, GPCRs can traffic to and signal from many profile of CXCR3 changes as it traffics from the plasma membrane to endosomes in a ligand-specific manner
- Molecular basis for variations in the sensitivity of pathogenic rhodopsin variants to 9-cis-retinal
However, the magnitude of the response to this molecule varies considerably across this spectrum of mutations the coupling between binding and folding suggests underlying differences in stability constrains the magnitude Nevertheless, estimates from computational modeling suggest that many of the least sensitive variants
- The Gluopsins: Opsins without the Retinal Binding Lysine
This makes opsins light-sensitive. The gluopsins are mainly dragonfly and butterfly opsins, closely related to the RGR-opsins and the retinochromes
- Coincident Regulation of PLCβ Signaling by Gq-Coupled and μOpioid Receptors Opposes Opioid- Mediated
of PLCβ Signaling by Gq-Coupled and μOpioid Receptors Opposes Opioid- Mediated Antinociception "Pain management The current frontline approach for pain-management is the use of opioid analgesics.
- GPR125 (ADGRA3) is an autocleavable adhesion GPCR that traffics with Dlg1 to the basolateral...
modulate planar cell polarity in gastrulating zebrafish, but its biochemical properties and role in mammalian Knockdown of GPR125 as well as that of Dlg1 results in formation of aberrant cysts with multiple lumens in Matrigel
- Deciphering the signaling mechanisms of β-arrestin1 and β-arrestin2 in regulation of cancer cell...
cancer cell cycle and metastasis "β-Arrestins are ubiquitously expressed intracellular proteins with many
- Structure-Based Discovery of Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5
The mGlu5 receptor is activated by the main excitatory neurotransmitter of the nervous central system
- Conservation of Allosteric Ligand Binding Sites in G-Protein Coupled Receptors
These structures have been studied by protein mapping using the FTMap server, which determines the clustering Mapping of Alphafold2 generated models of these proteins confirms that the same sites can be identified We then mapped the 394 GPCR X-ray structures available at the time of the analysis (September 2020). Results show that for each of the 21 structures with bound ligands there exist many other GPCRs that These sites cluster at nine distinct locations, and each can be found in many different proteins.
- GPCRs steer G i and G s selectivity via TM5-TM6 switches as revealed by structures of serotonin...
The structures reveal that transmembrane helices TM5 and TM6 alternate lengths as a macro-switch to determine We find that the macro-switch by the TM5-TM6 length is shared by class A GPCR-G protein structures.
- Activation of the human chemokine receptor CX3CR1 regulated by cholesterol
upon activation than previously solved class A GPCR-Gi complex structures is observed in CX3CR1, which may